cholesteatoma of middle ear: A non-neoplastic lesion characterized by the proliferation of keratinizing squamous epithelium in the middle ear that results in the accumulation of keratin and cells. It is usually caused by repeated infections. If left untreated, it may increase in size and destroy the adjacent delicate bones of the middle ear.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1998 |
4. Check minimum number of eventsNone |
1998 |
5. Include endpointsNone |
1998 |
6. Filter based on genotype QC (FinnGen only) |
1998 |
Control definitions (FinnGen only)
- Control exclude
- H8_MIDDLEMASTOID
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H65-H75
- Name in latin
- Cholesteatoma auris mediae
Similar endpoints
↥List of similar endpoints to
Cholesteatoma of middle ear
based on the number of shared cases.
Similar with more cases:
- Diseases of middle ear and mastoid
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 17391 | 7390 | 9876 |
| Only index persons | 15196 | 6641 | 8555 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.25 | 0.21 | 0.28 |
| Only index persons | 0.29 | 0.24 | 0.33 |
| Median age at first event (years) | |||
| Whole population | 46.07 | 49.35 | 43.53 |
| Only index persons | 44.52 | 48.24 | 41.62 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1998 | 885 | 1113 |
| Unadjusted period prevalence (%) | 0.41 | 0.30 | 0.49 |
| Median age at first event (years) | 48.36 | 46.23 | 50.05 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1791
- Matched controls
- 17911
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
38700
ICD-8 Finland
Other disease of ear and mastoid process, Cholesteatoma of ear
+∞
323.0
414
*
H71
ICD-10 Finland
Cholesteatoma of middle ear
4503599627370496.0
323.0
1432
*
UDC00
NOMESCO Finland
Ear microscopy
16.0
323.0
592
536
3853A
ICD-9 Finland
Other disorders of middle ear and mastoid, Cholesteatoma of middle ear and mastoid
+∞
323.0
319
*
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
620.7
275.3
266
5
DC1AD
NOMESCO Finland
Temporalbone CT
116.9
258.8
277
28
H65.3
ICD-10 Finland
Chronic mucoid otitis media
558.2
250.2
243
5
DFF00
NOMESCO Finland
Pure tone audiometry
8.8
215.9
518
795
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
29.9
208.0
284
112
Z01.1
ICD-10 Finland
Examination of ears and hearing
6.5
198.5
604
1294
DEB25
NOMESCO Finland
Attico-antro-mastoidectomy and tympanoplasty
+∞
196.5
185
*
DCD10
NOMESCO Finland
Tympanoplasty
2112.2
188.9
180
*
DEA10
NOMESCO Finland
Attico-antrotomy
+∞
176.0
166
*
38110
ICD-8 Finland
Otitis media without mention of mastoiditis, Chronic
+∞
171.7
162
*
H70.1
ICD-10 Finland
Chronic mastoiditis
+∞
166.3
157
*
DEB30
NOMESCO Finland
Radical mastoidectomy
1656.5
155.5
149
*
H66.0
ICD-10 Finland
Acute suppurative otitis media
13.8
154.6
278
235
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
216.3
154.6
158
8
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
242.1
152.7
155
7
DCD00
NOMESCO Finland
Myringoplasty
1545.2
146.9
141
*
4147
FHL
Radical surgery, cavity filling and middle ear and / or eardrum plastic
+∞
131.9
125
*
H74.1
ICD-10 Finland
Adhesive middle ear disease
+∞
127.6
121
*
38210
ICD-8 Finland
Chronic otitis media with mastoiditis
+∞
125.5
119
*
H90.1
ICD-10 Finland
Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side
28.0
120.0
166
65
H66.9
ICD-10 Finland
Otitis media, unspecified
11.0
116.4
233
241
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
305.6
113.4
114
*
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
3.7
105.9
564
1961
DEB20
NOMESCO Finland
Attico-antro-mastoidectomy and tympanotomy
+∞
105.2
100
*
H65.2
ICD-10 Finland
Chronic serous otitis media
227.3
104.8
107
5
3821A
ICD-9 Finland
Suppurative and unspecified otitis media, Chronic tubotympanic suppurative otitis media
+∞
94.6
90
*
H90.7
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
23.7
91.1
132
60
DBD20
NOMESCO Finland
Plastic repair of external auditory canal
80.7
88.2
99
13
TDA90
NOMESCO Finland
Removal wax from ear
20.4
84.9
129
68
DEB10
NOMESCO Finland
Attico-antro-mastoidectomy
+∞
84.0
80
*
H95.0
ICD-10 Finland
Recurrent cholesteatoma of postmastoidectomy cavity
+∞
84.0
80
*
H72.2
ICD-10 Finland
Other marginal perforations of tympanic membrane
432.1
83.7
83
*
H95.1
ICD-10 Finland
Other disorders following mastoidectomy
+∞
79.8
76
*
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
38.7
77.9
99
27
H60.9
ICD-10 Finland
Otitis externa, unspecified
5.7
75.2
231
450
S02CA02
ATC
flumetasone and antiinfectives; otic
5.8
74.7
226
432
H60.4
ICD-10 Finland
Cholesteatoma of external ear
84.9
72.7
81
10
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
10.2
71.4
146
154
H90.0
ICD-10 Finland
Conductive hearing loss, bilateral
30.9
70.2
94
32
H72.9
ICD-10 Finland
Perforation of tympanic membrane, unspecified
68.7
68.9
79
12
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
4.4
67.3
265
674
Z3229
NOMESCO Finland
Other healthcare associate professional
4.0
64.1
289
831
4151
FHL
Reoperation for chronic otitis media
+∞
62.9
60
*
H65.4
ICD-10 Finland
Other chronic nonsuppurative otitis media
329.4
62.8
63
*
H66.1
ICD-10 Finland
Chronic tubotympanic suppurative otitis media
329.4
62.8
63
*
Z97.4
ICD-10 Finland
Presence of external hearing-aid
5.2
62.0
205
432
H60.3
ICD-10 Finland
Other infective otitis externa
10.8
61.3
121
119
4143
FHL
Atticotomy or atticoanthromy through the ear canal
+∞
58.7
56
*
4150
FHL
Tympanoplasty (including for reasons other than inflammation)
290.2
55.5
56
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.4
55.4
588
2981
4146
FHL
Radical cutting (bridge broken)
+∞
54.4
52
*
DFF15
NOMESCO Finland
Speech audiometry
5.3
54.4
175
356
4145
FHL
Tympanomastoidectomy, includes possible tympanoplasty
257.0
49.3
50
*
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
5.1
49.0
165
352
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.1
48.8
932
6102
H74.2
ICD-10 Finland
Discontinuity and dislocation of ear ossicles
+∞
48.1
46
*
38100
ICD-8 Finland
Otitis media without mention of mastoiditis, Acute
+∞
47.1
45
*
R5120
NOMESCO Finland
Preparation of an aid
6.7
47.0
124
196
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
6.0
46.3
134
239
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
+∞
46.0
44
*
4122
FHL
Tympanostomy (tympanic tube)
225.3
43.1
44
*
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
6.2
42.7
120
206
H72.1
ICD-10 Finland
Attic perforation of tympanic membrane
115.3
41.9
45
*
H95.8
ICD-10 Finland
Other postprocedural disorders of ear and mastoid process
+∞
41.8
40
*
4141
FHL
Myringoplasty (also for reasons other than inflammation)
+∞
40.8
39
*
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
5.5
40.2
125
243
H60.8
ICD-10 Finland
Other otitis externa
7.1
40.1
101
149
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
44.7
39.2
48
11
H65.0
ICD-10 Finland
Acute serous otitis media
15.4
38.6
64
43
DDD05
NOMESCO Finland
Plastic repair of ossicular chain
+∞
36.6
35
*
DEB35
NOMESCO Finland
Radical mastoidectomy with tympanoplasty
+∞
36.6
35
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.6
35.9
288
1213
DCB00
NOMESCO Finland
Excision of lesion of middle ear
+∞
35.5
34
*
38402
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) non definita
+∞
34.5
33
*
38199
ICD-8 Finland
Otitis media without mention of mastoiditis, Unspecified
+∞
33.4
32
*
H61.2
ICD-10 Finland
Impacted cerumen
3.5
33.1
166
510
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
75.6
32.9
37
5
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
5.5
31.4
96
183
DAX08
NOMESCO Finland
Fitting of hearing aid
4.0
31.4
131
345
DGW00
NOMESCO Finland
Dilatation of eustachian tube
+∞
31.3
30
*
1450
FHL
Otomicroscopy
47.1
30.7
37
8
DCA30
NOMESCO Finland
Exploration of middle ear
152.4
28.7
30
*
38401
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) chronica adhaesiva
+∞
28.2
27
*
H66.2
ICD-10 Finland
Chronic atticoantral suppurative otitis media
+∞
28.2
27
*
ZXC10
NOMESCO Finland
Use of laser
5.9
27.5
79
140
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
8.1
27.3
62
79
J01MA02
ATC
ciprofloxacin; systemic
1.7
26.2
720
4975
J01DA01
ATC
[U] cefalexin; systemic
1.7
25.9
1078
8407
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
25.6
499
3075
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
12.4
25.6
46
38
Z98.8
ICD-10 Finland
Other specified postsurgical states
9.1
25.6
54
61
H72.8
ICD-10 Finland
Other perforations of tympanic membrane
50.8
25.3
30
6
J01CA04
ATC
amoxicillin; systemic
1.8
25.1
1352
11339
UDC10
NOMESCO Finland
Tympanoscopy
253.5
24.7
25
*
DCW99
NOMESCO Finland
Other operation on eardrum and middle ear
+∞
24.0
23
*
4144
FHL
Mastoidectomy or aticomastoidectomy
+∞
24.0
23
*
38299
ICD-8 Finland
Unspecified otitis media with mastoiditis
+∞
23.0
22
*
3842A
ICD-9 Finland
Other disorders of tympanic membrane, Perforation of tympanic membrane
+∞
23.0
22
*
H92.0
ICD-10 Finland
Otalgia
3.6
22.5
106
310
ZXE20
NOMESCO Finland
More than three and less than five hours
2.1
22.3
292
1542
R5140
NOMESCO Finland
Monitoring the use of the aid
2.3
22.0
214
988
3820A
ICD-9 Finland
Suppurative and unspecified otitis media, Acute suppurative otitis media
+∞
21.9
21
*
4148
FHL
Radical cutting and cavity filling
+∞
21.9
21
*
H90.8
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, unspecified
14.8
21.2
35
24
H66
ICD-10 Finland
Suppurative and unspecified otitis media
5.9
21.1
59
102
ZXA00
NOMESCO Finland
Right side
1.7
20.6
501
3277
S02AA03
ATC
boric acid; otic
8.8
20.6
44
51
DEB00
NOMESCO Finland
Cortical mastoidectomy
111.3
20.6
22
*
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
3.4
19.8
100
309
DED00
NOMESCO Finland
Obliteration of cavity after partial excision of mastoid
+∞
19.8
19
*
H04
ICPC
Ear discharge
3.8
19.1
81
218
H61.3
ICD-10 Finland
Acquired stenosis of external ear canal
17.3
18.7
29
17
DEE00
NOMESCO Finland
Osseous fixation of hearing aid
101.1
18.6
20
*
H69.0
ICD-10 Finland
Patulous Eustachian tube
38.8
18.6
23
6
ZXA05
NOMESCO Finland
Left side
1.7
18.0
471
3129
ZZG00
NOMESCO Finland
Graft of cartilage
53.1
18.0
21
*
H60.5
ICD-10 Finland
Acute otitis externa, noninfective
9.4
17.6
36
39
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
16.8
643
4698
H70.0
ICD-10 Finland
Acute mastoiditis
63.9
16.8
19
*
4111
FHL
Ear canal extension
+∞
16.7
16
*
H83.1
ICD-10 Finland
Labyrinthine fistula
161.3
15.5
16
*
J01DA06
ATC
[U] cefuroxime; systemic
1.9
15.5
248
1402
H01
ICPC
Ear pain/earache
2.2
15.3
169
825
R4135
NOMESCO Finland
Rehabilitation for hearing problems
4.3
14.9
55
131
H60
ICD-10 Finland
Otitis externa
3.0
14.6
84
286
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
14.6
601
4433
38400
ICD-8 Finland
Other inflammatory diseases of ear, Rhinosalpingitis (otosalpingitis) acuta
+∞
14.6
14
*
H73.8
ICD-10 Finland
Other specified disorders of tympanic membrane
+∞
14.6
14
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.3
14.5
142
653
R01AD08
ATC
fluticasone; nasal
1.6
14.4
420
2843
H61.8
ICD-10 Finland
Other specified disorders of external ear
5.7
14.2
40
71
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
2.1
14.0
156
762
J01DC02
ATC
cefuroxime; systemic
2.6
14.0
100
392
H90.2
ICD-10 Finland
Conductive hearing loss, unspecified
11.5
13.8
25
22
H91.9
ICD-10 Finland
Hearing loss, unspecified
2.8
13.8
89
328
J01DB01
ATC
cefalexin; oral
1.5
13.7
1342
11845
DCW00
NOMESCO Finland
Removal of ventilating tube from tympanic membrane
+∞
13.6
13
*
H74.4
ICD-10 Finland
Polyp of middle ear
+∞
13.6
13
*
H29
ICPC
Ear symptom/complaint other
2.0
13.5
172
891
EMB30
NOMESCO Finland
Adenotomy
6.5
12.6
32
50
H72
ICD-10 Finland
Perforation of tympanic membrane
70.4
12.6
14
*
H73.1
ICD-10 Finland
Chronic myringitis
+∞
12.5
12
*
H74.3
ICD-10 Finland
Other acquired abnormalities of ear ossicles
+∞
12.5
12
*
DDD20
NOMESCO Finland
Interposition between eardrum and footplate of stapes
+∞
12.5
12
*
DE2DG
NOMESCO Finland
Acoustic channel very extensive MRI examination with high intensity magnet
24.5
12.5
17
7
DDD10
NOMESCO Finland
Interposition between malleus and stapes
130.9
12.4
13
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
12.2
109
483
4451
FHL
Guitar cutting
4.8
12.1
39
82
R01AD09
ATC
mometasone; nasal
1.5
12.1
644
4973
H80.0
ICD-10 Finland
Otosclerosis involving oval window, nonobliterative
6.0
12.0
32
54
J01DA08
ATC
[U] cefaclor; oral
1.9
11.6
162
869
3824A
ICD-9 Finland
Suppurative and unspecified otitis media, Unspecified suppurative otitis media
+∞
11.5
11
*
R42
ICD-10 Finland
Dizziness and giddiness
1.6
11.3
353
2418
4121
FHL
Tympanic puncture or parasentosis in general anesthesia or operating room
17.1
11.2
17
10
H71
ICPC
Acute otitis media/myringitis
6.4
11.1
28
44
RK520
NOMESCO Finland
NA
8.6
11.0
23
27
DC1BD
NOMESCO Finland
Temporal bone extensive CT
43.6
10.9
13
*
DBD10
NOMESCO Finland
Reconstruction of external auditory canal
110.6
10.4
11
*
DCA40
NOMESCO Finland
Fat patching or other similar technique without opening of tympanic membrane
+∞
10.4
10
*
ZXD20
NOMESCO Finland
Day surgery
1.8
10.3
197
1177
Z97.8
ICD-10 Finland
Presence of other specified devices
10.7
10.3
19
18
R01BA52
ATC
pseudoephedrine, combinations; oral
1.5
10.2
438
3213
N07CA01
ATC
betahistine; oral
2.0
10.1
127
655
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
10.0
308
2095
H02AB06
ATC
prednisolone; systemic
1.4
9.7
726
5908
DBB00
NOMESCO Finland
Excision of lesion of external auditory canal
13.4
9.7
16
12
H74.0
ICD-10 Finland
Tympanosclerosis
100.5
9.4
10
*
38408
ICD-8 Finland
Other inflammatory diseases of ear, Alii definiti
30.2
9.4
12
*
H92.1
ICD-10 Finland
Otorrhoea
17.6
9.4
14
8
5251
FHL
Hypotension
+∞
9.4
9
*
H80.9
ICD-10 Finland
Otosclerosis, unspecified
5.9
9.4
25
43
RK120
NOMESCO Finland
NA
12.4
9.4
16
13
H60.0
ICD-10 Finland
Abscess of external ear
9.6
9.3
18
19
ZXA10
NOMESCO Finland
Bilateral
1.5
8.7
296
2058
RK110
NOMESCO Finland
NA
5.5
8.6
24
44
J35.2
ICD-10 Finland
Hypertrophy of adenoids
5.2
8.5
25
49
DCB10
NOMESCO Finland
Freeing of adhesions of middle ear
+∞
8.3
8
*
3810A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Acute nonsuppurative otitis media
+∞
8.3
8
*
3851A
ICD-9 Finland
Other disorders of middle ear and mastoid, Adhesive middle ear disease
+∞
8.3
8
*
H60.1
ICD-10 Finland
Cellulitis of external ear
5.2
8.2
24
47
38798
ICD-8 Finland
Other disease of ear and mastoid process, Alii definiti
11.7
8.1
14
12
RK320
NOMESCO Finland
NA
4.5
8.1
27
61
WX110
NOMESCO Finland
Local anesthesy
1.3
7.9
1038
9114
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.4
7.8
350
2577
DEW99
NOMESCO Finland
Other operation on mastoid and temporal bone
45.2
7.7
9
*
J01FA10
ATC
azithromycin; systemic
1.3
7.7
808
6858
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.4
7.6
400
3031
H92.2
ICD-10 Finland
Otorrhagia
10.1
7.5
14
14
H81.3
ICD-10 Finland
Other peripheral vertigo
2.6
7.4
51
198
DBW99
NOMESCO Finland
Other operation on external auditory canal
+∞
7.3
7
*
1451
FHL
Otomicroscopy and paper place
+∞
7.3
7
*
N02BE01
ATC
paracetamol; systemic, rectal
1.4
7.1
1401
12958
RK530
NOMESCO Finland
NA
20.1
7.1
10
5
T16
ICD-10 Finland
Foreign body in ear
5.3
7.1
20
38
J01FA09
ATC
clarithromycin; systemic
1.4
7.0
425
3300
AA1AD
NOMESCO Finland
CT of head and brain
1.4
6.9
382
2917
H74.9
ICD-10 Finland
Disorder of middle ear and mastoid, unspecified
40.2
6.8
8
*
DFF59
NOMESCO Finland
Other assessment of balance
4.9
6.7
20
41
ZXE00
NOMESCO Finland
One hour or less
1.3
6.7
583
4787
H02
ICPC
Hearing complaint
1.6
6.5
186
1241
4161
FHL
Exploratory tympanotomy
70.1
6.4
7
*
DC1AA
NOMESCO Finland
Temporalbone X-ray examination
70.1
6.4
7
*
TDM10
NOMESCO Finland
Puncture of maxillary antrum
2.3
6.4
55
244
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
2.9
6.4
37
131
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.9
6.3
86
463
DDA10
NOMESCO Finland
Exploration of ossicular chain
+∞
6.3
6
*
4119
FHL
Other measure in this category
+∞
6.3
6
*
H74.8
ICD-10 Finland
Other specified disorders of middle ear and mastoid
+∞
6.3
6
*
A02BC01
ATC
omeprazole; systemic
1.3
6.2
428
3384
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.4
6.2
257
1857
R01AD12
ATC
fluticasone furoate; nasal
1.4
6.2
358
2751
H73.0
ICD-10 Finland
Acute myringitis
12.6
6.1
10
8
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
500
1848
3.27
103.95
2.1
1.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
324
1883
1.86
21.06
1.5
1.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
329
2391
1.45
8.15
2.0
2.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1274
11733
1.24
4.86
4.0
4.1
mm/h
12.8
13.2
0.49
1185
10795
(4062490)
31
133
2.35
4.67
1.9
1.3
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
30
131
2.31
4.36
1.9
1.3
g/l
0.3
0.4
1.29
19
92
(3028192) IgG subclass 2 [Mass/volume] in Serum
30
131
2.31
4.36
1.9
1.3
g/l
2.8
2.9
0.09
19
93
(3027135) IgG subclass 1 [Mass/volume] in Serum
30
131
2.31
4.36
1.9
1.3
g/l
6.6
7.2
0.61
19
92
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
777
6895
1.21
4.00
2.0
2.0
pmol/l
93.4
93.9
0.08
413
3596
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1252
11653
1.20
3.72
4.0
3.9
pmol/l
14.9
14.9
0.09
1120
10448
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1643
15721
1.25
3.64
16.2
15.6
mg/l
25.9
25.7
0.09
1356
12667
(3024980) IgG subclass 4 [Mass/volume] in Serum
39
210
1.87
3.36
2.0
1.5
g/l
0.5
0.8
1.50
25
162
(3038177) Helicobacter pylori Ab [Presence] in Serum
38
203
1.89
3.35
1.2
1.3
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1496
14239
1.20
3.15
4.9
4.7
mu/l
2.1
2.0
0.02
1338
12884
(3019550) Sodium [Moles/volume] in Serum or Plasma
1694
16325
1.25
3.14
19.5
18.4
mmol/l
139.7
139.6
0.34
1645
15908
(3023103) Potassium [Moles/volume] in Serum or Plasma
1697
16359
1.25
3.13
19.5
18.5
mmol/l
4.0
4.0
0.30
1648
15915
(3013826) Glucose [Moles/volume] in Serum or Plasma
1058
9788
1.17
3.10
4.8
4.9
mmol/l
6.8
6.8
0.31
992
9189
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
22
4.10
2.88
1.1
1.4
ng/l
77.5
102.5
—
9
22
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1313
12412
1.17
2.77
6.8
7.6
u/l
78.4
79.6
0.34
1226
11660
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
19
86
2.22
2.64
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
19
86
2.22
2.64
1.0
1.0
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1717
16638
1.23
2.61
10.7
10.7
u/l
25.8
26.2
0.31
1650
16006
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
78
546
1.45
2.48
2.0
1.5
titre
106.7
186.3
—
6
19
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
385
3346
1.19
2.34
4.2
3.9
ng/l
195.9
693.9
1.13
325
2748
(3006922) Hepatitis E virus Ab [Presence] in Serum
19
91
2.10
2.33
1.0
1.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1587
15311
1.18
2.29
4.7
4.5
mmol/l
4.5
4.5
0.59
1447
14049
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
14
59
2.38
2.29
1.7
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1180
11155
1.14
2.22
4.7
4.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
580
5233
1.15
2.18
3.3
3.1
ng/l
1885.6
1629.2
0.31
498
4507
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1618
15655
1.18
2.16
5.3
5.1
mmol/l
2.6
2.7
0.28
1468
14283
(3003338) MCHC [Mass/volume]
1350
12891
1.15
2.15
21.5
20.3
g/l
332.4
332.3
0.04
1337
12782
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1572
15178
1.17
2.14
4.6
4.5
mmol/l
1.4
1.4
1.49
1419
13827
(3031040) Bacteria [#/volume] in Urine by Automated count
1138
10751
1.14
2.12
5.0
4.7
e6/l
1294.9
1833.4
0.15
22
169
(3035350) Ketones [Presence] in Urine by Test strip
837
7760
1.14
2.08
3.8
3.8
estimate
0.0
0.0
0.00
133
1503
(3013115) Eosinophils [#/volume] in Blood
883
8222
1.13
2.04
5.9
5.9
e9/l
0.2
0.2
0.97
763
7193
(3044007) Cell count panel - Peritoneal fluid
0
58
0.00
2.03
0.0
2.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
9
32
2.82
2.00
1.2
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1505
14511
1.15
1.98
6.3
6.1
mmol/mol
40.4
40.3
0.16
1385
13323
(3023368) Bacteria identified in Blood by Culture
542
4897
1.15
1.98
4.4
4.4
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
411
3644
1.16
1.95
3.8
3.7
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
816
7579
1.13
1.94
6.1
6.1
mmol/l
1.2
1.2
0.19
741
6837
(3024731) MCV [Entitic volume]
1773
17326
1.21
1.93
24.0
22.8
fl
91.2
91.3
0.15
1743
17047
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
889
8304
1.13
1.92
6.8
6.9
mmol/l
1.2
1.2
0.49
764
6975
(3035941) MCH [Entitic mass]
1773
17328
1.21
1.92
24.0
22.7
pg
30.4
30.4
0.16
1742
17046
(3026361) Erythrocytes [#/volume] in Blood
1773
17329
1.21
1.91
24.1
22.8
e12/l
4.5
4.5
0.70
1718
16818
(3007461) Platelets [#/volume] in Blood
1772
17319
1.20
1.90
24.2
22.8
e9/l
246.0
244.8
0.33
1724
16863
(3019225) pH of Specimen
202
1687
1.22
1.90
3.3
4.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1773
17332
1.20
1.89
24.3
23.0
g/l
135.0
134.7
0.44
1743
17054
(3020564) Creatinine [Moles/volume] in Serum or Plasma
1707
16632
1.18
1.88
19.4
18.4
umol/l
82.9
81.1
0.84
1707
16626
(3010813) Leukocytes [#/volume] in Blood
1773
17333
1.20
1.88
24.2
22.9
e9/l
7.0
6.8
1.18
1716
16820
(3022217) INR in Platelet poor plasma by Coagulation assay
275
2372
1.18
1.83
29.8
27.5
inr
1.5
1.4
0.63
49
334
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
238
2027
1.20
1.83
4.5
4.6
%
31.7
32.8
0.68
155
1328
(3019198) Lymphocytes [#/volume] in Blood
870
8134
1.12
1.82
5.9
5.7
e9/l
1.9
1.9
0.55
762
7129
(3020682) Albumin/Creatinine [Ratio] in Urine
585
5339
1.14
1.82
4.0
4.0
mg/mmol
7.4
9.8
0.85
363
3427
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
35
224
1.57
1.76
4.6
6.5
mg/l
11.6
11.8
0.05
30
209
(3018010) Neutrophils/100 leukocytes in Blood
810
7554
1.12
1.76
6.2
5.8
%
57.7
58.0
0.20
758
7072
(3044640) Blood type and Crossmatch panel - Blood
576
5265
1.13
1.74
2.1
2.5
—
—
—
0
0
(3013512) EKG study
543
4948
1.13
1.72
4.2
4.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1573
15260
1.14
1.71
4.9
4.7
mmol/l
6.0
6.0
0.02
1426
13755
(3019069) Monocytes/100 leukocytes in Blood
805
7514
1.12
1.71
6.5
6.2
%
8.8
8.8
0.01
751
7038
(3019309) Folate [Moles/volume] in Red Blood Cells
379
3373
1.15
1.71
1.8
1.8
nmol/l
1065.5
1173.0
1.49
279
2527
(3002030) Lymphocytes/100 leukocytes in Blood
822
7682
1.12
1.71
6.3
6.0
%
26.9
26.9
0.07
765
7163
(3006315) Basophils [#/volume] in Blood
850
7960
1.12
1.70
5.9
5.7
e9/l
0.0
0.0
1.42
737
6854
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
556
5084
1.13
1.67
2.2
2.2
u/l
260.5
240.8
0.12
520
4772
(3019832) Treponema pallidum Ab [Presence] in Serum
82
1065
0.76
1.67
1.6
1.6
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
759
7069
1.12
1.66
9.6
10.4
inr
1.3
1.3
0.56
184
2009
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1517
14691
1.14
1.66
4.1
4.0
mmol/l
1.3
1.3
0.10
1374
13275
(40768443) Skin Pathology biopsy report
88
678
1.31
1.65
1.3
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
578
5307
1.13
1.61
3.4
3.2
mmol/l
7.6
7.5
0.27
474
4432
(3020393) Adenovirus Ag [Presence] in Stool
5
14
3.58
1.61
1.8
1.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1666
16248
1.15
1.59
15.5
14.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
672
6230
1.12
1.59
2.2
2.2
—
—
—
0
0
(40758558) Short blood count panel - Blood
441
3988
1.14
1.57
6.6
6.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
844
7927
1.11
1.57
5.8
5.6
e9/l
0.6
0.6
0.73
733
6812
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
187
1583
1.20
1.56
2.4
2.5
ug/l
5.6
7.5
1.47
157
1390
(3006504) Eosinophils/100 leukocytes in Blood
799
7484
1.11
1.56
6.3
5.9
%
2.9
2.8
0.25
744
6973
(3019150) Specific gravity of Urine by Refractometry
384
3444
1.14
1.55
4.1
4.2
kg/l
1.0
1.0
0.46
66
509
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
87
1108
0.78
1.54
1.7
1.7
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
13
64
2.04
1.54
1.2
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
62
459
1.36
1.53
1.5
1.6
iu/ml
26.7
14.4
0.17
18
94
(3014271) Vancomycin [Susceptibility]
18
100
1.81
1.53
3.8
2.7
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
15
3.34
1.52
2.0
2.9
u/field
0.0
0.5
—
5
15
(3009261) Glucose [Presence] in Urine by Test strip
836
7859
1.11
1.51
3.9
3.8
estimate
0.0
0.0
0.50
136
1462
(3051611) Lipemic interference index of Serum or Plasma
27
172
1.58
1.43
3.9
3.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
184
1570
1.19
1.43
4.0
3.0
ng/l
235.6
222.9
0.09
173
1434
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1515
14718
1.12
1.42
15.4
14.7
ml/min/173m2
78.3
77.7
0.47
1268
12168
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
445
4054
1.13
1.41
2.1
2.4
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
6
137
0.44
1.40
1.0
1.1
—
0.6
—
0
36
(3021960) Folate [Moles/volume] in Serum or Plasma
448
4085
1.12
1.40
1.5
1.6
nmol/l
19.3
20.3
0.70
380
3458
(3022096) Basophils/100 leukocytes in Blood
774
7272
1.11
1.39
6.3
5.9
%
0.6
0.7
0.28
719
6792
(3012516) Albumin [Mass/volume] in Urine
547
5050
1.11
1.37
3.3
3.3
mg/l
382.8
282.4
0.21
340
3276
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
87
690
1.27
1.36
1.9
1.9
u/l
39.9
38.6
0.21
72
601
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
91
726
1.27
1.35
1.9
1.9
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
822
7760
1.10
1.33
5.2
5.1
estimate
0.0
0.0
0.50
144
1517
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
14
246
0.57
1.32
1.5
1.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
970
9235
1.10
1.31
8.2
8.9
e9/l
4.3
4.2
0.37
833
8060
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
38
267
1.43
1.30
1.1
1.2
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
219
0.55
1.30
1.7
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
474
4355
1.12
1.30
2.5
2.8
umol/l
7628.2
6154.3
0.24
413
3751
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1043
9972
1.10
1.27
3.0
3.2
u/l
50.1
53.1
0.41
962
9207
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
8
35
2.29
1.27
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
8
35
2.29
1.27
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
8
35
2.29
1.27
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
8
35
2.29
1.27
1.1
1.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
474
4365
1.11
1.24
2.3
2.2
mg/l
2.7
3.0
3.06
398
3697
(3052592) Norovirus Ag [Presence] in Stool
8
36
2.23
1.24
1.1
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
8
36
2.23
1.24
1.9
1.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
643
6017
1.10
1.23
4.0
4.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
105
863
1.23
1.23
2.6
2.4
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
67
523
1.29
1.21
1.7
1.6
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
765
7229
1.09
1.18
4.7
4.9
g/l
35.1
35.0
0.15
700
6694
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
691
6501
1.10
1.18
3.9
3.9
ng/l
119.5
57.1
0.33
498
4782
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
690
6494
1.10
1.16
5.1
5.1
ug/l
3.1
3.9
0.43
604
5803
(3026389) Candida sp identified in Specimen by Organism specific culture
28
190
1.48
1.16
1.3
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
92
751
1.24
1.16
3.4
2.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
30
207
1.46
1.15
1.4
1.4
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
274
2456
1.13
1.14
1.2
1.2
iu/ml
42.6
36.1
0.18
82
769
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
553
5156
1.10
1.14
2.6
2.6
u/l
55.4
57.3
0.48
523
4752
(3022313) Gas panel - Capillary blood
102
844
1.22
1.14
3.6
3.8
—
—
—
0
0
(4281824)
8
155
0.51
1.13
1.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
17
103
1.66
1.12
1.4
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
17
103
1.66
1.12
1.4
1.3
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
119
1407
0.84
1.12
4.1
3.7
mmol/l
1.2
1.2
0.74
100
1212
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
13
73
1.79
1.11
1.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
30
209
1.44
1.10
1.4
1.4
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
320
2906
1.12
1.09
2.0
1.8
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
598
5608
1.09
1.08
2.9
3.4
mmol/l
2.3
2.3
0.33
518
4849
(3017732) Neutrophils [#/volume] in Blood
125
1061
1.19
1.08
2.8
3.3
e9/l
4.2
4.2
0.07
89
809
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
106
886
1.21
1.08
1.4
1.3
au/ml
83.6
49.5
—
8
39
(3002032) Base excess in Venous blood by calculation
188
1650
1.15
1.08
3.6
3.6
mmol/l
2.1
1.9
0.23
146
1309
(3007164) IgA [Mass/volume] in Serum or Plasma
313
2842
1.12
1.07
1.4
1.4
g/l
2.4
2.6
1.03
198
1717
(44816559) Phosphatidylethanol [Mass/volume] in Blood
18
278
0.64
1.06
1.1
1.3
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
22
325
0.67
1.05
1.2
1.3
mmol/l
66.1
61.7
0.18
17
261
(40768441) Liver Pathology biopsy report
6
121
0.49
1.05
1.0
1.4
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
15
241
0.62
1.05
2.5
2.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
62
490
1.27
1.05
4.4
3.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
13
216
0.60
1.04
1.3
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
50
644
0.77
1.04
2.6
3.2
u/ml
33.2
6440.6
0.85
41
544
(3000850) Epithelial cells [#/volume] in Urine
392
3611
1.11
1.03
2.9
2.6
e6/l
5.2
5.1
0.00
334
3191
(3006245) CD3-CD19+ cells/100 cells in Blood
10
53
1.89
1.01
1.1
2.8
%
5.7
7.2
—
10
47
(4010399)
135
1162
1.17
1.01
1.4
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
680
6434
1.09
1.00
2.2
2.2
nmol/l
80.2
77.8
1.29
593
5680
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
81
665
1.23
1.00
1.8
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
17
107
1.59
0.99
3.8
3.7
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
0
29
0.00
0.97
0.0
2.6
—
41.5
—
0
10
(40758292) HTLV I+II Ab panel - Serum
0
29
0.00
0.97
0.0
1.3
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
30
0.00
0.97
0.0
3.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
738
7015
1.08
0.96
9.8
9.9
e9/l
0.0
0.0
0.44
617
5742
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
42
319
1.32
0.96
1.4
1.8
pmol/l
191.1
203.2
0.54
36
303
(3014891) Appearance of Pleural fluid
0
32
0.00
0.95
0.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
29
208
1.40
0.94
1.4
1.4
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
133
1151
1.17
0.94
3.7
3.7
kpa
5.2
5.2
0.29
120
1067
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
16
101
1.59
0.93
1.4
1.8
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
445
4148
1.09
0.92
3.4
4.0
%
86.3
86.6
0.08
429
4048
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
12
196
0.61
0.92
1.5
1.6
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
32
235
1.37
0.91
2.6
2.5
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
190
1692
1.14
0.91
2.1
2.2
ug/g
134.0
140.8
0.13
145
1326
(3009343) pH of Capillary blood
131
1136
1.16
0.91
3.7
3.7
ph
7.4
7.4
—
9
139
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
345
3180
1.10
0.91
1.2
1.2
u/ml
2.5
1.7
0.41
98
818
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
247
2237
1.12
0.90
1.4
1.4
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
34
451
0.75
0.90
5.0
3.4
mg/l
1.8
1.6
0.57
28
408
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
82
683
1.21
0.90
1.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
11
182
0.60
0.89
1.6
1.7
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
85
714
1.20
0.86
3.8
4.0
mmol/l
24.9
24.8
0.05
77
668
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
160
1804
0.88
0.86
3.9
4.1
ug/l
5.7
20.7
2.28
133
1510
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
72
866
0.83
0.86
2.0
1.8
g/l
1.5
1.5
0.01
60
754
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
801
7674
1.07
0.83
4.0
4.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
923
8889
1.07
0.82
2.7
2.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
440
4122
1.09
0.82
1.7
1.6
mmol/l
1.4
1.4
0.93
374
3437
(3005570) Glucose [Moles/volume] in Urine
24
172
1.40
0.81
1.8
2.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
114
991
1.16
0.79
2.6
2.4
au/ml
27.3
19.6
—
6
46
(3050129) First trimester maternal screen panel - Serum or Plasma
21
293
0.71
0.79
1.4
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
109
946
1.16
0.78
1.6
1.8
g/l
1.1
1.5
2.10
101
862
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
226
2060
1.11
0.76
7.6
7.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
45
359
1.26
0.76
1.4
1.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
584
5555
1.07
0.74
5.9
5.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
68
570
1.20
0.73
4.8
7.2
mmol/l
1.4
1.3
0.02
63
504
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
550
5221
1.07
0.73
4.7
4.5
%
21.2
21.7
0.32
279
2611
(3045424) Erythrocytes [Presence] in Urine
33
254
1.30
0.73
1.9
1.4
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
24
176
1.37
0.72
1.4
1.3
nmol/l
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
6
107
0.56
0.72
1.5
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
289
2675
1.09
0.72
1.8
2.1
s
29.7
30.1
0.41
279
2590
(1761868) Lipid panel - Serum or Plasma
481
5082
0.93
0.72
3.0
3.0
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
297
2754
1.09
0.71
3.0
3.3
mmol/l
0.8
0.8
0.03
275
2563
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
35
273
1.29
0.71
1.8
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
138
1229
1.13
0.70
4.6
5.0
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
28
365
0.76
0.70
1.3
1.3
miu/ml
254.0
238.0
—
10
155
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
91
1048
0.86
0.69
7.6
7.5
mmol/l
24.6
24.8
0.34
91
1042
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
9
142
0.63
0.69
1.4
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
30
387
0.77
0.69
2.4
2.5
%
16.8
15.8
0.76
15
190
(3037522) Nuclear Ab [Titer] in Serum
215
1966
1.10
0.69
1.3
1.3
titre
498.8
532.2
0.11
51
418
(40768795) Lymph node Pathology biopsy report
9
146
0.61
0.69
1.4
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
61
726
0.84
0.69
1.3
1.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
123
1089
1.14
0.69
3.7
3.7
mmol/l
1.5
1.8
0.51
92
814
(3020891) Body temperature
83
714
1.17
0.68
4.9
4.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
110
967
1.15
0.68
9.9
10.6
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
27
1.85
0.68
1.4
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
139
1243
1.13
0.67
1.8
1.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
339
3171
1.08
0.67
2.7
3.1
mmol/l
2.5
2.5
0.32
293
2788
(3021447) Carbon dioxide [Partial pressure] in Venous blood
183
1663
1.11
0.67
3.7
3.6
kpa
5.8
5.8
0.18
178
1613
(3020779) Urea [Moles/volume] in Serum or Plasma
176
1596
1.11
0.67
6.2
7.2
mmol/l
11.7
10.5
1.16
167
1519
(3022145) Colonoscopy Study observation
189
1721
1.11
0.67
1.3
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
403
4272
0.93
0.66
1.3
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
13
86
1.51
0.66
3.2
3.7
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
16
111
1.45
0.66
1.9
1.5
promille
1.0
1.2
0.26
11
90
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
45
367
1.23
0.65
1.2
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
27
206
1.31
0.65
1.4
1.4
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
42
515
0.81
0.65
1.8
1.8
mg/l
2.5
3.2
0.76
32
374
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
168
1849
0.90
0.64
3.7
3.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
29
1.73
0.64
1.0
1.0
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
248
2296
1.09
0.63
5.5
5.6
mmol/l
1.1
1.0
0.39
229
2112
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
12
177
0.68
0.63
2.7
2.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
43
351
1.23
0.62
2.8
2.2
u/l
3292.1
4735.1
0.26
15
139
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
61
516
1.19
0.62
1.3
1.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
104
1.45
0.62
1.3
2.3
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
225
2076
1.09
0.62
7.5
7.4
mmol/l
1.1
1.1
0.03
174
1611
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
11
71
1.55
0.62
1.0
1.2
iu/ml
176.0
215.3
0.33
11
71
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
8
49
1.64
0.62
2.1
1.3
ug/l
7.5
9.1
—
8
49
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
44
361
1.22
0.61
1.4
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
14
199
0.70
0.61
1.1
1.4
—
—
—
0
0
(4034850)
59
499
1.19
0.61
8.7
11.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
39
316
1.24
0.61
1.2
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
46
554
0.83
0.61
1.5
1.6
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
29
227
1.28
0.60
1.8
2.4
mg/l
11.6
22.8
—
8
55
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
13
186
0.70
0.59
2.7
3.7
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
47
563
0.83
0.59
1.8
2.3
g/l
38.0
37.3
0.38
41
486
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
22
0.00
0.59
0.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
33
410
0.80
0.59
1.4
1.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
53
446
1.19
0.58
1.0
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
23
0.00
0.58
0.0
3.2
—
—
—
0
0
(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid
0
23
0.00
0.58
0.0
1.2
—
46.3
—
0
8
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
92
811
1.14
0.58
2.2
2.4
%
0.7
0.7
0.03
87
780
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
20
149
1.35
0.57
1.1
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
20
149
1.35
0.57
1.1
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
20
149
1.35
0.57
1.1
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
8
54
1.48
0.57
1.0
1.8
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
6
36
1.67
0.56
2.0
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
127
1406
0.90
0.56
4.1
4.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
23
176
1.31
0.56
2.6
3.1
nmol/l
12.2
5.3
0.39
23
171
(3000991) Gas panel - Venous blood
162
1481
1.10
0.55
8.7
8.1
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
90
0.55
0.55
1.0
1.6
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
37
1.62
0.55
1.0
1.1
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
34
275
1.24
0.55
1.4
1.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
13
90
1.45
0.55
1.0
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
13
90
1.45
0.55
1.0
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
13
90
1.45
0.55
1.0
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
13
90
1.45
0.55
1.0
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
148
0.67
0.55
1.7
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
6
38
1.58
0.54
1.7
3.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
14
99
1.42
0.54
2.0
1.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
37
448
0.82
0.53
1.3
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
45
377
1.20
0.53
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
45
377
1.20
0.53
1.3
1.3
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
17
227
0.75
0.53
1.1
1.4
e6/l
12328.6
84757.6
—
8
136
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
172
1582
1.10
0.53
1.8
1.6
—
—
—
0
0
(3002256) Pathology report gross observation
222
2066
1.08
0.52
1.3
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
26
205
1.27
0.52
1.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
26
205
1.27
0.52
1.4
1.4
—
—
—
0
0
(4024509)
19
143
1.33
0.52
1.4
1.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
9
63
1.43
0.52
1.3
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
24
304
0.79
0.52
1.4
1.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
14
100
1.40
0.51
1.0
1.0
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
51
434
1.18
0.51
1.8
2.1
mg/l
9.3
11.9
1.59
45
395
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
10
145
0.69
0.50
1.0
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
65
1.39
0.50
1.1
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
122
1107
1.11
0.50
1.4
1.4
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
43
508
0.84
0.49
1.5
1.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
25
311
0.80
0.48
1.5
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
234
2193
1.08
0.47
1.3
1.2
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
100
901
1.12
0.47
1.2
1.2
iu/ml
146.6
137.6
0.09
41
336
(3011412) CD3 cells [#/volume] in Blood
18
137
1.32
0.47
1.4
2.2
e9/l
1.3
1.0
0.40
12
87
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
665
0.87
0.47
2.3
2.5
g/l
10.2
10.5
0.25
50
566
(40768800) Prostate Pathology biopsy report
48
411
1.17
0.46
1.1
1.2
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
222
2079
1.08
0.46
7.6
7.4
kpa
5.0
5.1
0.27
215
1987
(3013139) Helicobacter pylori Ag [Presence] in Stool
105
950
1.11
0.46
1.3
1.3
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
40
472
0.84
0.46
1.3
1.5
ug/g
307.4
272.2
0.68
27
286
(3051387) C reactive protein [Mass/volume] in Capillary blood
43
365
1.18
0.46
3.8
3.5
mg/l
19.7
27.8
1.44
26
234
(3027801) Oxygen [Partial pressure] in Arterial blood
222
2080
1.08
0.46
7.6
7.4
kpa
12.6
12.1
0.49
214
1991
(21494434) Karyotype in Bone marrow
13
176
0.74
0.46
1.0
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
8
120
0.67
0.45
1.0
1.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
611
5907
1.05
0.45
4.2
3.8
e6/l
53.9
108.9
2.36
449
4307
(3004616) Nuclear Ab [Presence] in Serum
25
201
1.25
0.45
1.1
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
10
69
1.45
0.44
2.8
3.0
mu/l
22.6
22.7
—
10
64
(3041096) Erythrocytes [Presence] in Urine by Automated
438
4201
1.05
0.44
3.5
3.5
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
881
8595
1.04
0.44
5.4
6.2
umol/l
11.4
12.0
0.77
843
8147
(3000093) Morphology [Interpretation] in Blood Narrative
20
157
1.28
0.43
1.2
1.1
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
55
628
0.87
0.43
1.5
1.9
—
—
—
0
0
(44790049)
15
196
0.76
0.43
1.5
1.5
—
—
—
0
0
(44790048)
15
196
0.76
0.43
1.5
1.5
—
—
—
0
0
(44790047)
15
196
0.76
0.43
1.5
1.5
—
—
—
0
0
(44806118)
15
196
0.76
0.43
1.5
1.5
—
—
—
0
0
(3022621) pH of Urine by Test strip
114
1042
1.10
0.42
3.2
3.2
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
34
285
1.20
0.42
2.7
3.4
%
1.1
1.7
0.27
24
221
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
38
446
0.85
0.42
1.9
2.4
%
203.7
196.0
0.17
33
426
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
215
2020
1.07
0.42
2.0
1.7
—
—
—
0
0
(3000012) Reticulocyte production index
12
87
1.38
0.42
1.2
1.6
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
17
131
1.30
0.42
1.1
1.3
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
17
131
1.30
0.42
1.2
2.0
umol/l
4.0
6.9
1.20
11
89
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
57
1.41
0.42
3.9
2.6
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
8
57
1.41
0.42
1.4
1.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
23
185
1.25
0.42
1.3
1.3
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
20
158
1.27
0.41
1.3
1.3
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
529
5108
1.05
0.41
3.4
3.3
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
33
1.52
0.41
1.2
1.3
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count
0
15
0.00
0.41
0.0
1.8
—
17.1
—
0
8
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
49
426
1.15
0.41
1.2
1.3
—
—
—
0
0
(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid
0
17
0.00
0.40
0.0
2.0
—
62.4
—
0
12
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
215
2024
1.07
0.40
1.9
1.8
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
194
0.77
0.40
1.4
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
246
2327
1.07
0.40
1.5
1.8
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
59
521
1.14
0.40
1.9
1.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
60
1.33
0.40
2.0
2.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
36
422
0.85
0.40
1.3
1.5
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
25
303
0.82
0.39
1.3
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
7
102
0.69
0.39
1.1
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
7
103
0.68
0.39
1.7
1.5
g/l
1.0
1.0
—
7
103
(1175426) CD3 cells/100 lymphocytes in Blood
14
106
1.32
0.39
1.3
2.3
%
74.9
72.5
0.35
14
99
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
32
270
1.19
0.38
1.1
1.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
19
236
0.80
0.38
4.1
3.8
u/ml
25.9
33.7
0.37
19
230
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
141
1311
1.08
0.37
3.9
3.8
ng/l
95.5
92.2
0.17
118
1126
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
173
1622
1.07
0.37
2.0
2.2
g/l
0.2
0.2
0.04
162
1508
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
11
147
0.75
0.37
1.2
1.3
u/l
11.6
12.6
0.12
11
134
(40761535) Cells panel - Urine sediment
148
1381
1.08
0.36
3.7
3.6
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
76
0.66
0.35
1.0
1.2
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
35
406
0.86
0.35
4.7
5.0
kpa
4.9
5.1
0.67
35
400
(3017315) Amylase [Enzymatic activity/volume] in Urine
5
78
0.64
0.35
1.4
1.2
u/l
230.6
388.5
—
5
71
(3016502) Oxygen saturation in Arterial blood
197
1860
1.07
0.35
7.8
7.8
%
95.6
95.6
0.01
192
1796
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
85
775
1.10
0.35
1.9
2.0
ug/l
1.3
2.6
0.82
74
686
(3024928) Oxygen saturation in Venous blood
31
363
0.85
0.35
2.7
2.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
232
2203
1.06
0.35
6.7
6.7
mmol/l
104.4
104.3
0.06
223
2144
(3023520) Reticulocytes [#/volume] in Blood
166
1559
1.07
0.35
2.2
2.5
e9/l
67.1
69.7
0.46
124
1207
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
24
199
1.21
0.35
1.3
1.6
%
57.5
63.7
0.33
15
126
(3012501) Base excess in Blood by calculation
35
405
0.86
0.35
4.7
5.0
mmol/l
2.2
2.8
1.15
25
272
(3014133) Dog dander IgE Ab [Units/volume] in Serum
12
156
0.77
0.34
1.0
1.1
u/ml
19.7
3.6
—
7
57
(4198724)
6
44
1.36
0.34
1.7
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
29
246
1.18
0.34
1.4
1.5
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
45
396
1.14
0.34
1.5
1.7
e6/l
8380.4
15017.3
1.51
28
284
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
32
274
1.17
0.34
4.4
2.9
—
—
—
0
0
(3010421) pH of Blood
42
478
0.88
0.34
4.2
4.6
ph
7.4
7.4
0.45
35
399
(3017181) Myelocytes/100 leukocytes in Blood
147
1377
1.07
0.33
4.3
4.0
%
0.9
0.9
0.08
45
410
(3005719) IgG [Mass/volume] in Serum or Plasma
127
1183
1.08
0.33
2.1
2.7
g/l
10.6
10.7
0.10
118
1080
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
45
1.33
0.33
1.3
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
12
91
1.32
0.33
1.8
3.0
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
24
200
1.20
0.33
1.3
1.3
nmol/l
0.7
0.6
0.51
24
189
(3023323) Follitropin [Units/volume] in Serum or Plasma
44
387
1.14
0.33
1.2
1.3
iu/l
25.4
27.4
0.16
37
322
(3004588) Protein electrophoresis panel - Serum or Plasma
116
1248
0.93
0.33
2.1
2.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
47
416
1.13
0.33
1.1
1.1
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
19
155
1.23
0.32
1.2
1.2
u/l
89.2
57.4
1.88
11
111
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
14
176
0.79
0.32
1.1
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
524
5091
1.04
0.32
2.9
3.2
u/l
35.8
39.3
0.28
490
4831
(3002173) Hemoglobin [Mass/volume] in Arterial blood
179
1694
1.06
0.31
8.4
8.3
g/l
121.0
121.0
0.01
174
1638
(3009542) Hematocrit [Volume Fraction] of Blood
1421
14057
1.04
0.31
18.2
16.7
%
39.6
39.5
0.09
931
9499
(3036071) Salmonella sp Ab [Titer] in Serum
7
52
1.35
0.31
1.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
24
202
1.19
0.31
1.0
1.1
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
53
1.32
0.30
1.3
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
185
1755
1.06
0.30
1.3
1.4
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
60
543
1.11
0.30
5.1
3.9
mmol/l
3.8
3.9
0.98
55
501
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
10
75
1.34
0.30
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
46
410
1.12
0.30
1.3
1.2
—
—
—
0
0
(4035726)
132
1405
0.94
0.30
1.6
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
110
1026
1.08
0.29
1.3
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
218
2080
1.05
0.29
2.1
2.5
%
1.7
1.8
0.28
188
1837
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
64
702
0.91
0.29
2.1
2.5
g/l
3.8
3.8
0.07
45
519
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
12
152
0.79
0.29
2.2
2.4
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
106
0.75
0.29
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
106
0.75
0.29
1.0
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
106
0.75
0.29
1.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
17
139
1.22
0.29
1.0
1.2
—
33.3
—
0
6
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
109
0.73
0.29
1.0
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
109
0.73
0.29
1.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
109
0.73
0.29
1.0
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
348
3361
1.04
0.29
4.5
4.5
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
15
121
1.24
0.28
1.0
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
27
312
0.86
0.28
1.6
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
51
460
1.11
0.28
1.5
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
74
681
1.09
0.27
2.3
1.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
77
834
0.92
0.27
4.4
3.8
mmol/l
23.6
24.0
0.47
69
754
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
64
1.25
0.27
1.0
1.0
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
36
406
0.88
0.27
4.7
5.0
kpa
8.3
8.4
0.08
36
400
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
16
131
1.22
0.27
1.0
1.1
—
56.8
—
0
13
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
110
1031
1.07
0.27
1.5
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
16
193
0.83
0.26
1.1
1.5
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
16
193
0.83
0.26
1.1
1.1
u/ml
6.0
6.2
—
8
97
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
21
178
1.18
0.26
1.1
1.4
pmol/l
243.8
289.6
0.25
16
139
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
39
436
0.89
0.26
2.2
2.3
ug/min
180.5
87.7
0.58
23
267
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
51
463
1.10
0.25
1.2
1.1
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
72
1.25
0.25
1.3
1.2
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
31
351
0.88
0.25
1.4
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
529
5167
1.03
0.25
3.6
3.3
e6/l
59.8
84.5
0.63
418
4041
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
9
75
1.20
0.25
2.1
2.7
u/ml
565.4
1319.3
—
9
75
(3014051) Protein [Presence] in Urine by Test strip
32
361
0.88
0.25
2.8
2.3
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
118
1113
1.06
0.25
10.1
9.0
%
0.6
0.7
1.05
118
1104
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
12
148
0.81
0.24
1.2
1.4
%
46.3
29.3
—
6
91
(3042631) Mycobacterium sp identified in Specimen
29
255
1.14
0.24
2.4
2.6
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
6
81
0.74
0.24
1.7
1.3
—
1.4
—
0
5
(3000764) Benzodiazepines [Presence] in Urine
44
398
1.11
0.24
4.2
2.3
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
6
84
0.71
0.24
1.3
1.5
%
61.3
62.8
—
6
65
(36660697) Celiac disease serology panel - Serum
118
1115
1.06
0.24
1.1
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
203
1948
1.05
0.23
1.4
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
91
853
1.07
0.23
3.4
3.3
pmol/l
4.3
4.5
0.68
79
743
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
702
0.92
0.23
2.1
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
702
0.92
0.23
2.1
2.5
g/l
7.3
7.5
0.28
46
533
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
171
1.17
0.23
1.4
1.4
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
17
143
1.19
0.23
1.0
1.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
21
181
1.16
0.22
7.5
2.8
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
93
0.75
0.22
1.6
1.5
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
102
962
1.06
0.22
10.0
9.2
mmol/l
24.2
24.3
0.17
97
897
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
79
1.27
0.22
1.4
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
79
1.27
0.22
1.4
1.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
679
6671
1.03
0.22
3.0
2.8
ug/l
134.3
143.5
0.30
624
6087
(3014765) Yersinia sp identified in Stool by Organism specific culture
51
468
1.09
0.22
1.2
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
439
4286
1.03
0.22
4.5
4.1
estimate
0.0
0.0
0.88
131
1450
(3023199) Leukocytes [#/volume] in Pleural fluid
22
252
0.87
0.21
1.2
1.4
e6/l
15797.9
1731.6
0.68
15
184
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
22
252
0.87
0.21
1.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
5
42
1.19
0.21
1.4
1.1
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
11
0.00
0.21
0.0
2.0
—
2.2
—
0
11
(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.3
—
20.3
—
0
6
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.1
—
5.0
—
0
6
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
4.3
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.3
—
37.2
—
0
6
(3037121) Protein [Mass/volume] in Urine
66
614
1.08
0.21
2.7
3.4
g/l
0.4
0.3
0.39
28
244
(3018418) pH of Serum or Plasma
504
4934
1.03
0.21
4.4
4.0
ph
7.4
7.4
0.00
82
956
(1617658) Protocol used for examination of sentinel lymph nodes
8
104
0.77
0.21
1.3
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
5
43
1.16
0.21
2.4
3.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
12
145
0.83
0.21
1.1
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
44
402
1.10
0.21
4.2
2.2
—
—
—
0
0
(4027681)
11
89
1.24
0.21
1.1
1.1
—
—
—
0
0
(3019768) Coxiella burnetii Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
11
134
0.82
0.20
1.5
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
166
1593
1.05
0.20
1.3
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
89
839
1.06
0.20
1.3
1.2
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
21
240
0.87
0.20
3.1
2.5
u/ml
33.9
1331.8
0.62
21
230
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
281
2727
1.04
0.20
3.1
3.0
e6/l
2.4
1.9
0.42
149
1531
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3025315) Body weight
0
14
0.00
0.20
0.0
4.7
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
14
0.00
0.20
0.0
1.0
—
6.0
—
0
14
(3024316) Viscosity of Plasma
0
14
0.00
0.20
0.0
1.5
—
1.4
—
0
9
(3008401) Mugwort IgE Ab [Units/volume] in Serum
16
187
0.85
0.20
1.0
1.1
u/ml
0.6
2.4
—
5
79
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
655
0.93
0.20
1.8
2.6
g/l
3.1
3.1
0.13
45
527
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
32
288
1.11
0.20
1.3
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
482
4721
1.03
0.19
3.5
3.2
e6/l
0.2
0.5
5.31
367
3636
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
56
603
0.93
0.19
1.9
2.6
g/l
0.9
1.3
0.51
51
519
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
298
2897
1.03
0.19
2.9
2.8
e6/l
1.3
1.3
0.09
168
1693
(1001926) Buprenorphine [Presence] in Urine by Screen method
35
317
1.11
0.19
4.8
2.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
99
1.21
0.19
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
22
193
1.14
0.19
2.6
3.9
—
—
—
0
0
(4094501)
46
423
1.09
0.19
1.1
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
21
239
0.88
0.19
1.2
1.1
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
51
1.18
0.19
1.0
1.1
—
—
—
0
0
(4015189)
6
51
1.18
0.19
2.3
1.8
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
44
404
1.09
0.19
4.3
2.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
11
90
1.22
0.19
2.1
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
23
203
1.13
0.19
3.2
7.9
mmol/l
9.2
7.6
0.42
15
171
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
13
154
0.84
0.19
1.0
1.1
%
103.3
96.5
0.54
13
145
(3043238) Trisomy 21 risk [Likelihood] in Fetus
17
196
0.87
0.18
1.5
1.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
26
232
1.12
0.18
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
26
232
1.12
0.18
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
26
232
1.12
0.18
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
26
232
1.12
0.18
1.5
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
23
259
0.89
0.18
1.3
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
51
473
1.08
0.18
1.2
1.1
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
7
58
1.21
0.18
1.4
1.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
43
396
1.09
0.18
2.0
2.1
—
—
—
0
0
(3026782) Osmolality of Urine
350
3418
1.03
0.18
3.1
2.8
mosm/kgh2o
555.1
553.8
0.04
293
2916
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
212
2053
1.04
0.18
3.0
4.0
u/l
236.8
248.3
0.71
203
1938
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
13
153
0.85
0.18
1.3
1.1
u/ml
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
24
214
1.12
0.17
1.6
1.6
—
—
—
0
0
(4268621)
12
142
0.84
0.17
2.1
2.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
135
1296
1.04
0.17
4.5
4.0
%
0.1
0.1
1.07
38
376
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
7
62
1.13
0.17
1.1
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
22
247
0.89
0.17
1.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
132
1267
1.04
0.17
1.7
2.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
11
131
0.84
0.17
1.5
1.6
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
19
167
1.14
0.17
1.0
1.1
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
117
1121
1.05
0.16
10.0
8.9
%
1.2
1.3
1.37
117
1113
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
12
141
0.85
0.16
1.3
1.4
u/l
13.8
13.7
0.01
12
132
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
8
70
1.14
0.16
1.0
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
8
70
1.14
0.16
1.0
1.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
20
177
1.13
0.16
1.4
1.3
mmol/l
7.2
7.4
0.09
12
123
(3017817) Protein [Mass] in Urine collected for unspecified duration
14
162
0.86
0.16
1.8
2.4
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
255
2484
1.03
0.16
3.0
2.5
g/l
2.3
2.3
0.32
238
2294
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
8
72
1.11
0.16
1.0
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
11
130
0.85
0.16
1.5
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
17
193
0.88
0.15
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
17
193
0.88
0.15
1.4
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
6
77
0.78
0.15
1.0
1.2
nmol/l
141.8
144.2
—
6
77
(1002224) Polysomnography panel
49
524
0.93
0.15
1.1
1.1
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1297
12879
1.02
0.15
19.8
18.9
%
13.8
13.8
0.00
1271
12597
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
6
79
0.76
0.15
14.2
20.0
nmol/l
1810.2
1527.8
—
6
79
(3022948) Iron [Moles/volume] in Serum or Plasma
275
2684
1.03
0.15
2.9
2.5
umol/l
12.5
12.7
0.19
252
2476
(3009214) Lutropin [Units/volume] in Serum or Plasma
34
369
0.92
0.15
1.2
1.4
u/l
8.6
8.6
0.00
25
294
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
16
182
0.88
0.15
1.2
1.0
u/ml
6.0
2.2
—
8
76
(21494890) Protein electrophoresis panel - 24 hour Urine
17
192
0.88
0.14
1.4
2.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
243
2370
1.03
0.14
1.3
1.2
u/ml
14.0
12.4
0.13
97
883
(3017569) Oxygen content in Arterial blood
7
88
0.79
0.14
1.3
1.7
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
7
90
0.78
0.14
1.1
1.5
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
13
112
1.16
0.14
1.4
1.4
pmol/l
69.1
71.6
—
7
34
(3016879) Cocaine [Presence] in Urine
40
372
1.08
0.14
4.6
2.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
141
1363
1.04
0.14
3.2
2.9
kpa
4.5
4.6
0.18
136
1318
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
373
3661
1.02
0.14
1.7
1.7
pmol/l
125503755.8
24503080.6
1.11
298
3016
(3023410) Appearance of Cerebral spinal fluid
14
160
0.87
0.14
1.4
1.4
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
45
421
1.07
0.14
3.0
3.2
nmol/l
0.7
0.8
0.66
33
335
(3014111) Lactate [Moles/volume] in Serum or Plasma
150
1549
0.97
0.14
7.9
6.8
mmol/l
1.3
1.4
1.03
145
1486
(3021901) Oxygen saturation in Capillary blood
36
334
1.08
0.13
3.0
3.0
—
—
—
0
0
(3011648) Oxygen content in Venous blood
12
138
0.87
0.13
1.0
1.7
%
9.6
10.8
0.64
12
138
(3025130) Human papilloma virus identified in Specimen
9
109
0.82
0.13
1.6
1.8
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
110
0.82
0.13
1.4
1.5
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
45
423
1.07
0.12
1.2
1.2
titre
80.0
81.8
—
6
39
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
19
171
1.11
0.12
1.0
1.1
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
85
1.18
0.12
1.1
1.0
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
37
395
0.94
0.12
1.1
1.2
u/ml
2.1
10.3
—
5
65
(1616796) Gas panel - Central venous blood
42
396
1.06
0.11
3.7
4.0
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
102
1055
0.97
0.11
1.3
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
23
211
1.09
0.11
1.1
1.1
—
13.9
—
0
10
(3003740) Influenza virus B Ag [Presence] in Specimen
23
211
1.09
0.11
1.0
1.1
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
12
105
1.14
0.11
1.0
1.1
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
63
603
1.05
0.10
2.5
3.4
mg/l
34.4
76.1
1.11
57
492
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
13
146
0.89
0.10
2.2
2.1
u/field
0.9
2.0
—
7
55
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
125
1.12
0.10
1.1
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
82
849
0.96
0.10
3.8
3.8
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
29
271
1.07
0.09
7.7
3.1
—
—
—
0
0
(4306422)
22
203
1.08
0.09
1.1
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
19
174
1.09
0.09
2.6
3.5
%
65.3
57.0
0.88
12
113
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
38
401
0.95
0.09
1.3
1.2
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
29
272
1.07
0.09
1.4
1.2
u/ml
272.7
261.4
0.09
21
162
(3004451) EKG impression Narrative
11
97
1.13
0.09
1.4
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
55
1.09
0.09
1.7
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
37
390
0.95
0.08
1.2
1.5
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
57
1.05
0.08
2.0
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
6
57
1.05
0.08
2.0
2.6
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
6
57
1.05
0.08
1.0
1.1
miu/ml
1567.5
1590.7
—
6
57
(3039162) Centromere protein B Ab [Units/volume] in Serum
16
175
0.91
0.08
1.1
1.2
—
50.0
—
0
8
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
107
1.12
0.08
1.3
2.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
23
214
1.08
0.08
1.2
1.2
u/ml
1.4
3.4
—
7
63
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
23
214
1.08
0.08
1.0
1.1
u/ml
3.0
1.8
—
9
90
(3021788) Differential panel - Synovial fluid
33
312
1.06
0.08
1.4
1.5
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
10
113
0.88
0.08
1.1
1.0
ng/l
688.2
624.5
—
5
63
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
10
113
0.88
0.08
1.1
1.0
ng/l
25.4
45.5
—
5
61
(3026470) Cobalt [Mass/volume] in Blood
10
113
0.88
0.08
2.6
2.0
ug/l
6.3
2.9
—
10
100
(3017446) Testosterone [Moles/volume] in Serum or Plasma
131
1280
1.03
0.08
2.2
2.2
nmol/l
12.1
12.9
0.73
120
1117
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
64
0.78
0.08
1.2
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
18
195
0.92
0.08
1.3
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
14
127
1.10
0.08
1.3
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
68
1.03
0.07
1.3
1.2
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
127
1242
1.02
0.07
3.8
3.9
%
0.5
0.7
0.59
31
297
(3019420) Tryptase [Mass/volume] in Serum or Plasma
6
72
0.83
0.07
1.0
1.6
ug/l
6.0
11.0
—
6
62
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
77
1.04
0.07
10.9
6.9
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
16
147
1.09
0.07
1.1
1.2
—
—
—
0
0
(44813793)
10
89
1.12
0.07
1.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
10
89
1.12
0.07
1.1
15.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
8
93
0.86
0.06
1.5
1.5
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
131
1285
1.02
0.06
2.5
2.9
ml/min/173m2
66.5
63.5
0.38
56
547
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
118
1156
1.02
0.06
1.8
1.9
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
16
148
1.08
0.06
1.3
1.3
e6/l
390954.3
130596.1
—
7
102
(3045142) Bone marrow Pathology biopsy report
19
203
0.94
0.06
1.2
1.3
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
26
274
0.95
0.06
1.5
1.4
u/ml
117.6
126.2
—
7
51
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
238
2351
1.01
0.06
3.1
2.6
%
21.7
22.6
0.50
190
2000
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
41
426
0.96
0.06
1.5
1.5
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
43
446
0.96
0.06
2.7
3.6
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
344
3408
1.01
0.06
1.6
1.7
mg/l
1.4
1.4
0.03
256
2630
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
25
237
1.06
0.05
1.8
1.5
—
—
—
0
0
(4146454)
19
178
1.07
0.05
2.4
2.6
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
373
3762
0.99
0.05
3.3
3.1
ug/l
0.9
0.8
0.64
255
2576
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
31
324
0.96
0.05
1.3
1.4
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
151
1533
0.98
0.05
2.0
2.4
u/l
354.3
39.7
0.49
128
1305
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
11
100
1.10
0.05
1.0
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
459
4558
1.01
0.05
3.5
3.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
12
110
1.09
0.05
1.1
1.4
—
195.0
—
0
12
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
34
327
1.04
0.05
1.6
1.8
nmol/l
1.1
0.8
0.85
27
269
(3025159) Blasts/100 leukocytes in Blood
124
1221
1.02
0.04
4.7
4.1
%
0.0
0.4
0.70
33
316
(3034770) Mitochondria Ab [Titer] in Serum
41
423
0.97
0.04
1.2
1.2
titre
—
1474.2
—
0
12
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
11
101
1.09
0.04
1.0
1.1
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
32
309
1.04
0.03
1.4
1.4
—
15.8
—
0
9
(3036481) Cortisol [Moles/volume] in Serum or Plasma
147
1453
1.01
0.03
2.1
2.2
nmol/l
390.3
370.8
0.61
129
1328
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
165
1667
0.99
0.03
1.5
1.8
%
1.5
1.5
0.05
142
1430
(3044889) 12 lead EKG panel
1122
11246
0.99
0.03
4.2
4.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
191
1.05
0.03
1.1
1.0
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
12
112
1.07
0.03
2.6
2.2
ug/min
67.4
172.6
—
5
26
(3006184) Hemoglobin [Mass/volume] in Capillary blood
38
370
1.03
0.03
2.1
2.2
g/l
133.3
128.1
0.63
29
273
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
22
229
0.96
0.03
1.5
1.5
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
13
122
1.07
0.02
1.0
1.1
—
4.8
—
0
6
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
46
470
0.98
0.02
1.6
1.7
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
33
321
1.03
0.02
3.7
3.3
e9/l
4.7
4.4
0.29
33
321
(3002523) Influenza virus A Ag [Presence] in Specimen
22
212
1.04
0.02
1.0
1.1
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
47
461
1.02
0.02
3.7
3.2
mmol/l
24.9
24.9
0.01
40
394
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
28
288
0.97
0.02
1.0
1.2
u/ml
14.7
40.2
—
5
23
(3019977) pH of Arterial blood
11
103
1.07
0.02
1.8
2.3
ph
7.5
7.4
—
5
34
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
10
107
0.93
0.02
1.1
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
45
443
1.02
0.01
1.3
1.4
—
—
—
0
0
(3036489) Thrombin time
61
603
1.01
0.01
1.5
2.0
s
20.9
21.6
0.68
50
538
(3034860) Kappa light chains.free [Mass/volume] in Serum
61
603
1.01
0.01
2.6
3.4
mg/l
41.4
155.2
0.65
55
491
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
12
126
0.95
0.00
1.2
1.1
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
14
146
0.96
0.00
1.3
2.0
—
1.4
—
0
7
(3023511) Choriogonadotropin [Units/volume] in Urine
18
174
1.03
0.00
1.2
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
21
204
1.03
0.00
1.4
1.2
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
206
0.97
0.00
1.2
1.2
u/ml
3.5
5.7
—
6
93
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
31
304
1.02
0.00
1.5
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
34
334
1.02
0.00
4.2
3.5
%
58.8
59.0
0.04
34
334
(3000492) Spirometry study
141
1404
1.00
0.00
1.4
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
105
0.95
0.00
1.2
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
195
0.97
0.00
1.1
1.1
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
22
225
0.98
0.00
1.3
1.4
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
23
235
0.98
0.00
1.1
1.1
iu/ml
343.6
33.3
—
5
53
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
18
181
0.99
0.00
1.0
1.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
35
345
1.01
0.00
1.5
1.9
iu/l
2.7
4.9
1.97
13
114
(3037756) Immunofixation for Serum or Plasma
40
395
1.01
0.00
1.5
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29
291
1.00
0.00
1.4
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
65
645
1.01
0.00
3.4
2.6
—
—
—
0
0
(3017704) Immunofixation for Urine
11
114
0.96
0.00
1.5
1.5
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
109
1091
1.00
0.00
1.9
1.6
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
12
124
0.97
0.00
1.3
1.1
—
136.7
—
0
27
(3020630) Protein [Mass/volume] in Serum or Plasma
149
1489
1.00
0.00
2.2
2.6
g/l
66.2
66.2
0.01
137
1354
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
20
204
0.98
0.00
1.0
1.1
%
119.3
116.2
0.26
20
186
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
35
354
0.99
0.00
1.7
1.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
72
722
1.00
0.00
1.5
1.3
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
59
588
1.00
0.00
2.5
3.4
ratio
2.7
1.8
—
9
49
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
26
258
1.01
0.00
1.4
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
98
1.02
0.00
1.1
1.1
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
10
97
1.03
0.00
1.0
2.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
10
97
1.03
0.00
1.0
2.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
10
103
0.97
0.00
2.2
2.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
19
193
0.98
0.00
2.2
1.5
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
46
463
0.99
0.00
4.8
4.7
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
185
1853
1.00
0.00
2.2
2.7
umol/l
8.8
9.2
0.10
161
1616
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
5.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
49
1.02
0.00
1.2
1.3
%
30.8
21.0
—
5
38
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.3
—
7.5
—
0
7
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
48
480
1.00
0.00
1.6
1.7
—
—
—
0
0
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.0
—
0
6
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
6
59
1.02
0.00
1.5
2.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
90
1.00
0.00
2.7
2.4
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
5
57
0.88
0.00
2.0
1.6
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
6
62
0.97
0.00
1.3
3.2
umol/l
62.7
121.6
—
6
37
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
8
85
0.94
0.00
1.4
1.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
5
52
0.96
0.00
1.0
1.1
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
53
0.94
0.00
2.4
2.2
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
70
1.00
0.00
1.1
1.2
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
2.6
—
0
8
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004347) Hepatitis D virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count
0
5
0.00
0.00
0.0
8.0
—
74.8
—
0
5
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
9
92
0.98
0.00
1.2
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
6
0.00
0.00
0.0
4.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
58
0.86
0.00
1.2
2.4
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
1745.2
—
0
5
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
63
630
1.00
0.00
3.0
2.8
u/ml
0.4
0.3
0.13
39
363
Mortality – FinRegistry
↥Association
Association between endpoint H8_CHOLEASTOMA and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_CHOLEASTOMA | 1.047 [0.94, 1.16] | 0.395 |
| Birth year | 0.997 [0.99, 1.01] | 0.45 |
During the follow-up period (1.1.1998 — 31.12.2019), 785 out of 4102 females with H8_CHOLEASTOMA died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_CHOLEASTOMA | 1.029 [0.93, 1.14] | 0.572 |
| Birth year | 0.99 [0.98, 1.0] | 0.038 |
During the follow-up period (1.1.1998 — 31.12.2019), 1025 out of 5237 males with H8_CHOLEASTOMA died.
Mortality risk
Mortality risk for people of age
years, who have H8_CHOLEASTOMA.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.123% | 0.193% |
| 5 | 0.634% | 1.217% |
| 10 | 1.682% | 3.257% |
| 15 | 3.035% | 6.167% |
| 20 | 5.517% | 10.486% |
Relationships between endpoints
↥Index endpoint: H8_CHOLEASTOMA – Cholesteatoma of middle ear
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data